{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:55Z","timestamp":1792264975736,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1124\/dmd.121.000455","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T19:20:18Z","timestamp":1639423218000},"page":"685-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights"],"prefix":"10.1016","volume":"50","author":[{"given":"Yangliu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000455_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/antiox9100965","article-title":"The late-stage protective effect of mito-TEMPO against acetaminophen-induced hepatotoxicity in mouse and three-dimensional cell culture models","volume":"9","author":"Abdullah-Al-Shoeb","year":"2020","journal-title":"Antioxidants"},{"key":"10.1124\/dmd.121.000455_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12010-018-2920-2","article-title":"Withaferin A protects against high-fat diet-induced obesity via attenuation of oxidative stress, inflammation, and insulin resistance","volume":"188","author":"Abu Bakar","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1124\/dmd.121.000455_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.119.089557","article-title":"Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver","volume":"48","author":"Bao","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000455_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.104.002402","article-title":"The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity","volume":"33","author":"Cheung","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000455_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.121.000455_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4573","article-title":"Studies on oral bioavailability and first-pass metabolism of withaferin A in rats using LC-MS\/MS and Q-TRAP","volume":"33","author":"Dai","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/dmd.121.000455_bib7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/cts.13009","article-title":"A metabolomic analysis of thiol response for standard and modified N-acetyl cysteine treatment regimens in patients with acetaminophen overdose","volume":"14","author":"Dear","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.121.000455_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/2231-4040.165023","article-title":"Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system","volume":"6","author":"Devkar","year":"2015","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1124\/dmd.121.000455_bib9","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3109\/13880209.2016.1157193","article-title":"Hepatoprotective effect of withanolide-rich fraction in acetaminophen-intoxicated rat: decisive role of TNF-\u03b1, IL-1\u03b2, COX-II and iNOS","volume":"54","author":"Devkar","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1124\/dmd.121.000455_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/971982","article-title":"Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation","volume":"2015","author":"Dey","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1124\/dmd.121.000455_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2018.00195","article-title":"Withaferin A associated differential regulation of inflammatory cytokines","volume":"9","author":"Dubey","year":"2018","journal-title":"Front Immunol"},{"key":"10.1124\/dmd.121.000455_bib12","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.3390\/ijms20215310","article-title":"Withania somnifera (ashwagandha) and withaferin A: potential in integrative oncology","volume":"20","author":"Dutta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.121.000455_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1389200221666200103111053","article-title":"Role of drug-metabolizing enzymes in cancer and cancer therapy","volume":"21","author":"Feng","year":"2020","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.121.000455_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/dmd.121.000455_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02928752","article-title":"Biotransformation of withaferin-A by a culture of arthrobacter simplex","volume":"30","author":"Funska","year":"1985","journal-title":"Folia Microbiol"},{"key":"10.1124\/dmd.121.000455_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02883237","article-title":"Microbiological and chemical dehydrogenation of withaferin A","volume":"32","author":"Fuska","year":"1987","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1124\/dmd.121.000455_bib17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as supportive treatment in liver diseases: a narrative review","volume":"37","author":"Gillessen","year":"2020","journal-title":"Adv Ther"},{"key":"10.1124\/dmd.121.000455_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2452848","article-title":"Withaferin A exerts preventive effect on liver fibrosis through oxidative stress inhibition in a sirtuin 3-dependent manner","volume":"2020","author":"Gu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/dmd.121.000455_bib19","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/carcin\/bgs209","article-title":"Controlled-release systemic delivery\u2014a new concept in cancer chemoprevention","volume":"33","author":"Gupta","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.121.000455_bib34858386","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.112807","article-title":"Withaferin A alleviates ethanol-induced liver injury by inhibiting hepatic lipogenesis","volume":"160","author":"Hamada","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1124\/dmd.121.000455_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2133\/dmpk.DMPK-11-RG-077","article-title":"Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development","volume":"27","author":"Hanada","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.121.000455_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tips.2014.02.001","article-title":"Insights into drug discovery from natural medicines using reverse pharmacokinetics","volume":"35","author":"Hao","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.121.000455_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.121.000455_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.08.004","article-title":"Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug","volume":"173","author":"Hassannia","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ecoenv.2012.02.003","article-title":"Protective effect of Withania somnifera against radiation-induced hepatotoxicity in rats","volume":"80","author":"Hosny Mansour","year":"2012","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1124\/dmd.121.000455_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jphp.13209","article-title":"Withanolides from the genus physalis: a review on their phytochemical and pharmacological aspects","volume":"72","author":"Huang","year":"2020","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2015.07.024","article-title":"Withaferin-A reduces acetaminophen-induced liver injury in mice","volume":"97","author":"Jadeja","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib28","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1074\/jbc.M606728200","article-title":"Withaferin A strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity","volume":"282","author":"Kaileh","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.121.000455_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218792","article-title":"Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice","volume":"14","author":"Khalilpourfarshbafi","year":"2019","journal-title":"PLoS One"},{"key":"10.1124\/dmd.121.000455_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4110\/in.2015.15.6.269","article-title":"Withaferin A inhibits helicobacter pylori-induced production of IL-1\u03b2 in dendritic cells by regulating NF-\u03baB and NLRP3 inflammasome activation","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw"},{"key":"10.1124\/dmd.121.000455_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.pnpbp.2007.09.011","article-title":"Withania somnifera: an Indian ginseng","volume":"32","author":"Kulkarni","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/dmd.121.000455_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113766","article-title":"Investigation of CYP2B6, 3A4 and \u03b2-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells","volume":"270","author":"Kumar","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.121.000455_bib33","doi-asserted-by":"crossref","first-page":"17943","DOI":"10.1038\/s41598-017-18190-4","article-title":"Concomitant activation of ETS-like transcription factor-1 and death receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice","volume":"7","author":"Kuppusamy","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.121.000455_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.4145","article-title":"Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"key":"10.1124\/dmd.121.000455_bib35","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.121.000455_bib36","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2009.03.022","article-title":"Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP","volume":"46","author":"Lee","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.121.000455_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.121.000455_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5567\/pharmacologia.2013.89.94","article-title":"Ameliorative potential of aqueous root extract of Withania somnifera against paracetamol induced liver damage in mice","volume":"4","author":"Malik","year":"2013","journal-title":"Pharmacologia"},{"key":"10.1124\/dmd.121.000455_bib39","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/molecules14072373","article-title":"Steroidal lactones from Withania somnifera, an ancient plant for novel medicine","volume":"14","author":"Mirjalili","year":"2009","journal-title":"Molecules"},{"key":"10.1124\/dmd.121.000455_bib40","first-page":"273","article-title":"Study on the anticarcinogenic efficacy of withaferin-A in DEN induced hepatocellular carcinoma: morphology and histopathology","volume":"5","author":"Murugan","year":"2015","journal-title":"Int J Health Sci Res"},{"key":"10.1124\/dmd.121.000455_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173340","article-title":"Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor","volume":"883","author":"Noori","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2008.09.017","article-title":"Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells","volume":"599","author":"Oh","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2016.10.003","article-title":"Withaferin A induces Nrf2-dependent protection against liver injury: role of Keap1-independent mechanisms","volume":"101","author":"Palliyaguru","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.121.000455_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.119.256792","article-title":"Withaferin A improves nonalcoholic steatohepatitis in mice","volume":"371","author":"Patel","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000455_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaim.2015.08.001","article-title":"Safety assessment of Withania somnifera extract standardized for withaferin A: acute and sub-acute toxicity study","volume":"7","author":"Patel","year":"2016","journal-title":"J Ayurveda Integr Med"},{"key":"10.1124\/dmd.121.000455_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2013.03.001","article-title":"Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract","volume":"80","author":"Patil","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.121.000455_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of withaferin-A in advanced stage high grade osteosarcoma: a phase I trial","volume":"11","author":"Pires","year":"2020","journal-title":"J Ayurveda Integr Med"},{"key":"10.1124\/dmd.121.000455_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ptr.5746","article-title":"Withanolides against TLR4-activated innate inflammatory signalling pathways: a comparative computational and experimental study","volume":"31","author":"Purushotham","year":"2017","journal-title":"Phytother Res"},{"key":"10.1124\/dmd.121.000455_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0039-128X(78)80007-5","article-title":"Microbial transformations of natural antitumor agents. 7. 14-alpha-hydroxylation of withaferin-A by cunninghamella elegans (NRRL 1393)","volume":"31","author":"Rosazza","year":"1978","journal-title":"Steroids"},{"key":"10.1124\/dmd.121.000455_bib50","first-page":"1501","article-title":"Withania somnifera L.: insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective","volume":"23","author":"Saleem","year":"2020","journal-title":"Iran J Basic Med Sci"},{"key":"10.1124\/dmd.121.000455_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0976-9234.116766","article-title":"Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, withaferin A, withanolide A and withanoside IV","volume":"4","author":"Savai","year":"2013","journal-title":"J Pharm Negat Results"},{"key":"10.1124\/dmd.121.000455_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/dmdi-2014-0035","article-title":"In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes","volume":"30","author":"Savai","year":"2015","journal-title":"Drug Metab Pers Ther"},{"key":"10.1124\/dmd.121.000455_bib53","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/biof.1546","article-title":"Withaferin A reverses bile duct ligation-induced liver fibrosis by modulating extracellular matrix deposition: role of LOXL2\/Snail1, vimentin, and NF\u03baB signaling","volume":"45","author":"Sayed","year":"2019","journal-title":"Biofactors"},{"key":"10.1124\/dmd.121.000455_bib54","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.121.000455_bib55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1124\/dmd.121.000455_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.628506","article-title":"Withaferin A acts as a novel regulator of liver X receptor-\u03b1 in HCC","volume":"10","author":"Shiragannavar","year":"2021","journal-title":"Front Oncol"},{"key":"10.1124\/dmd.121.000455_bib57","first-page":"271","article-title":"Antitumor activity of withaferin A (NSC-101088)","volume":"51","author":"Shohat","year":"1967","journal-title":"Cancer Chemother Rep"},{"key":"10.1124\/dmd.121.000455_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910050212","article-title":"Effect of withaferin A on Ehrlich ascites tumor cells-cytological observations","volume":"5","author":"Shohat","year":"1970","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.121.000455_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/cancers11040453","article-title":"Concomitant inhibition of cytoprotective autophagy augments the efficacy of withaferin A in hepatocellular carcinoma","volume":"11","author":"Siddharth","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1124\/dmd.121.000455_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12017-016-8411-0","article-title":"Withania somnifera and its withanolides attenuate oxidative and inflammatory responses and up-regulate antioxidant responses in BV-2 microglial cells","volume":"18","author":"Sun","year":"2016","journal-title":"Neuromolecular Med"},{"key":"10.1124\/dmd.121.000455_bib61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.120.000215","article-title":"The hypoglycemic effect of berberine and berberrubine involves modulation of intestinal farnesoid x receptor signaling pathway and inhibition of hepatic gluconeogenesis","volume":"49","author":"Sun","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000455_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.116.106617","article-title":"Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway","volume":"91","author":"Sun","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128255","article-title":"Biologically active metabolites in drug discovery","volume":"48","author":"Sun","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.121.000455_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2225-4110(16)30051-7","article-title":"Reverse pharmacology applicable for botanical drug development\u2014inspiration from the legacy of traditional wisdom","volume":"1","author":"Surh","year":"2011","journal-title":"J Tradit Complement Med"},{"key":"10.1124\/dmd.121.000455_bib65","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.biopha.2018.07.090","article-title":"Withaferin-A attenuates multiple low doses of streptozotocin (MLD-STZ) induced type 1 diabetes","volume":"106","author":"Tekula","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/dmd.121.000455_bib66","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.121.000455_bib67","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bcp.2012.08.027","article-title":"Molecular insight in the multifunctional activities of withaferin A","volume":"84","author":"Vanden Berghe","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib68","first-page":"138","article-title":"In vitro and in vivo evaluation of CYP1A interaction potential of terminalia arjuna bark","volume":"76","author":"Varghese","year":"2014","journal-title":"Indian J Pharm Sci"},{"key":"10.1124\/dmd.121.000455_bib69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.toxrep.2014.08.009","article-title":"Amelioration of bromobenzene hepatotoxicity by Withania somnifera pretreatment: role of mitochondrial oxidative stress","volume":"1","author":"Vedi","year":"2014","journal-title":"Toxicol Rep"},{"key":"10.1124\/dmd.121.000455_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10565-016-9340-2","article-title":"Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: possible involvement of mitochondrial dysfunction and inflammation","volume":"32","author":"Vedi","year":"2016","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.121.000455_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jff.2017.10.043","article-title":"Withanolides isolated from Nicandra physaloides protect liver cells against oxidative stress-induced damage","volume":"40","author":"Wang","year":"2018","journal-title":"J Funct Foods"},{"key":"10.1124\/dmd.121.000455_bib72","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4314\/tjpr.v14i6.10","article-title":"Withaferin A suppresses liver tumor growth in a nude mouse model by downregulation of cell signaling pathway leading to invasion and angiogenesis","volume":"14","author":"Wang","year":"2015","journal-title":"Trop J Pharm Res"},{"key":"10.1124\/dmd.121.000455_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.phytochem.2018.08.009","article-title":"Anti-inflammatory and cytotoxic withanolides from Physalis minima","volume":"155","author":"Wu","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1124\/dmd.121.000455_bib74","first-page":"48","article-title":"The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: evidences in inflammatory diseases and age-related disorders","volume":"27","author":"Wu","year":"2019","journal-title":"Yao Wu Shi Pin Fen Xi"},{"key":"10.1124\/dmd.121.000455_bib75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-020-03243-w","article-title":"Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1124\/dmd.121.000455_bib76","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation","volume":"46","author":"Yan","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000455_bib77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/dmd.116.069419","article-title":"Glycyrrhizin protects against acetaminophen-induced acute liver injury via alleviating tumor necrosis factor-\u03b1 mediated apoptosis","volume":"44","author":"Yan","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000455_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.121.000455_bib79","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1248\/bpb.29.1618","article-title":"Effects of dimethylsulfoxide on metabolism and toxicity of acetaminophen in mice","volume":"29","author":"Yoon","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.121.000455_bib80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in lean individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1124\/dmd.121.000455_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/taap.1998.8501","article-title":"Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice","volume":"152","author":"Zaher","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.121.000455_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/bst.2018.01247","article-title":"Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury","volume":"13","author":"Zhang","year":"2019","journal-title":"Biosci Trends"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:52:40Z","timestamp":1739955160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624007839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0090955624007839"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000455","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}